Liu C , Sherpa T , Varnum MD .

R01EY12836 NEI NIH HHS , R01 EY012836 NEI NIH HHS

             sensory perception of light stimulus

                macular degeneration

	Figure 1. Disease-associated mutations in CNGB3 alter the gating properties of heteromeric channels. A: Representative current traces are shown for CNGA3 plus CNGB3 channels after activation by saturating concentrations of CPT-cGMP (4 μM) or CPT-cAMP (100 μM). Current traces were elicited by voltage steps from a holding potential of 0 mV to +80 mV, −80 mV, and then back to 0 mV. B: Representative dose–response relationships for CPT-cGMP activation of CNG channels, after expression of CNGA3 plus CNGB3-WT (circles), T383fsX (squares), or F525N (triangles) subunits. Currents were normalized to the maximum cGMP current. Continuous curves represent fits of the dose–response relationship with the Hill equation as described in the Methods section. The parameters for each channel type were as follows: for WT, K1/2,CPT-cGMP=248 nM, h=1.5; for T383fsX, K1/2, cGMP=111 nM, h=1.9; and for F525N, K1/2,CPT-cGMP=79 nM, h=1.7.
	Figure 2. Disease-associated mutations in CNGB3 increase cytotoxicity. A: Western blot demonstrating expression of FLAG-tagged wild-type (WT) and mutant cone CNG channel subunits in 661W cells following transfection with indicated plasmids (above). Approximate locations of molecular weight markers (in kilodaltons) are indicated to the right of the immunoblot. Cell lysates were also probed with beta-actin antibody (below). The molecular weight of beta actin was ~42 kDa. B: The bar graph demonstrates increased cytotoxicity (measured as LDH release from dying cells) for cells expressing CNGA3 plus wild-type (WT) or mutant CNGB3 exposed to various concentrations of CPT-cGMP for 24 h (n=46 to 48). Cytotoxicity was normalized to that of control cells transfected with vector (pOPRSVI) alone, incubated in the absence of CPT-cGMP; *, significant difference between groups indicated by bracket (p<0.05); +, significant difference between F525N groups with or without 0.1 μM CPT-cGMP treatment (p<0.01).
	Figure 3. CNGB3 F525N mutation impairs cell viability with CPT-cGMP treatment. Transfected 661W cells were treated with or without 0.1 μM CPT-cGMP for 24 h. After treatment, cells were labeled according to the LIVE/DEAD assay protocol: vital cells were stained by calcein AM and show green fluorescence (A, C, E, and G); damaged cells were penetrated by ethidium homodimer and show red fluorescent nuclei (B, D, F and H). Fluorescent images were obtained using a Zeiss LSM 510 confocal laser-scanning microscope as described in the Methods section.
	Figure 4. CNGB3 F525N mutation increases annexin V–positive cells compared to wild-type channels. Transfected cells were treated with 0.1 μM CPT-cGMP for 24 h. For determination of cell death, cells were stained with fluorescein-labeled annexin V, a protein with a high affinity for phosphatidylserine (A and B). Cells were also counterstained with DAPI to count nuclei (C and D), and the two images were merged to count annexin V–positive cells (E and F). G: Summary bar graph for annexin V staining of cells transfected with control plasmid, wild-type CNGB3 plus CNGA3, or CNGB3-F525N plus CNGA3 plasmids. Fluorescent images were obtained using a Zeiss LSM 510 confocal system as described in the Methods. Scale bar in F (applies to A-F), 100 µm.
	Figure 5. Effect of combined exposure to CPT-cAMP and CPT-cGMP on cytotoxicity of cells expressing channels with disease-associated mutations in CNGB3. A: Representative dose–response relationships for CPT-cAMP activation of CNG channels, after coexpression of CNGA3 with CNGB3-WT (circles), T383fsX (squares), or F525N (triangles) subunits (same representative patches as in Figure 1B). Currents were normalized to the maximum CPT-cGMP current. Continuous curves represent fits of the dose–response relationship with the Hill equation. Parameters for each channel type were as follows: for WT, K1/2,CPT-cAMP=28.3 μM and h=1.4; for T383fsX, K1/2, cAMP=27.9 μM and h=1.6; and for F525N, K1/2,CPT-cAMP=10.8 μM and h=1.0. B: Bar graph of the relative cytotoxicity for channel-expressing cells exposed to various concentrations of CPT-cAMP plus 0.1 μM CPT-cGMP (n=12). The dashed line represents the percentage of cell death in the vector-only control group without treatment; * indicates significant difference between groups designated by bracket (p<0.05); + represents significant difference between the F525N group treated with 10 μM CPT-cAMP together with 0.1 μM CPT-cGMP and the F525N group without treatment (p<0.01).
	Figure 6. Block of CNG channels by L-cis-diltiazem increases viability of cells expressing CNGB3 with disease-associated mutations. A: Representative current traces elicited by 0.1 µM CPT-cGMP in the absence or presence (arrow) of 10 µM L-cis-diltiazem. Current traces were elicited by the voltage protocol described in the Methods section. B: Dose–response relationships for block by L-cis-diltiazem in the presence of 0.1 µM CPT-cGMP for heteromeric CNG channels containing CNGB3-WT (circles), T383fsX (squares), or F525N (triangles) subunits. Currents were normalized to the current elicited by 0.1 µM CPT-cGMP in the absence of L-cis-diltiazem. Continuous curves represent fits of the dose–response relation with the modified Hill equation described in the Methods section. Parameters for each channel type were as follows: WT, K1/2,L-cis-dilt.=4.1 µM and h=0.5; for T383fsX, K1/2,L-cis-dilt.=135 µM and h=0.3; and for F525N, K1/2,L-cis-dilt.=4.2 µM and h=0.7. C: Bar graph of the relative cytotoxicity for channel-expressing cells with or without 10 µM L-cis-diltiazem in the presence of 0.1 μM CPT-cGMP treatment (n=12). The dashed line indicates the extent of cell death in vector-only control cells without treatment. Significant differences were observed between groups indicated by brackets (*, p<0.05); + indicates significant difference between T383fsX groups treated with or without channel blocker (p<0.01).
	Figure 7. Removal of extracellular Ca2+ from culture media prevented the increase in cytotoxicity for cells expressing CNGB3 F525N. Bar graph of the relative cytotoxicity for channel-expressing cells treated with 0.1 μM CPT-cGMP in normal or Ca2+-free Dulbecco’s modified Eagle’s medium media (n=12; *, p<0.05). The dashed line indicates the level of cytotoxicity in control cells expressing pOPRSVI plasmid alone cultured in normal media without CPT-cGMP.

Azuma, Involvement of calpain isoforms in retinal degeneration in WBN/Kob rats. 2004, Pubmed

Azuma, Involvement of calpain isoforms in retinal degeneration in WBN/Kob rats. 2004, Pubmed
Brady, Interplay between PIP3 and calmodulin regulation of olfactory cyclic nucleotide-gated channels. 2006, Pubmed
Bright, Disease-associated mutations in CNGB3 produce gain of function alterations in cone cyclic nucleotide-gated channels. 2005, Pubmed , Xenbase
Bright, Regulation of human cone cyclic nucleotide-gated channels by endogenous phospholipids and exogenously applied phosphatidylinositol 3,4,5-trisphosphate. 2007, Pubmed , Xenbase
Brown, The pharmacology of cyclic nucleotide-gated channels: emerging from the darkness. 2006, Pubmed
Burns, Activation, deactivation, and adaptation in vertebrate photoreceptor cells. 2001, Pubmed
Chen, A new subunit of the cyclic nucleotide-gated cation channel in retinal rods. 1993, Pubmed , Xenbase
Choi, Calcium and excitotoxic neuronal injury. 1994, Pubmed
Craven, Salt bridges and gating in the COOH-terminal region of HCN2 and CNGA1 channels. 2004, Pubmed , Xenbase
Craven, C-terminal movement during gating in cyclic nucleotide-modulated channels. 2008, Pubmed , Xenbase
Crawford, Bcl-2 overexpression protects photooxidative stress-induced apoptosis of photoreceptor cells via NF-kappaB preservation. 2001, Pubmed
Danciger, A homozygous PDE6B mutation in a family with autosomal recessive retinitis pigmentosa. 1996, Pubmed
Delyfer, Inherited retinal degenerations: therapeutic prospects. 2004, Pubmed
Ding, Biochemical characterization of cone cyclic nucleotide-gated (CNG) channel using the infrared fluorescence detection system. 2012, Pubmed
Doonan, Caspase-independent photoreceptor apoptosis in mouse models of retinal degeneration. 2003, Pubmed
Duricka, Defective trafficking of cone photoreceptor CNG channels induces the unfolded protein response and ER-stress-associated cell death. 2012, Pubmed
Fain, Adaptation in vertebrate photoreceptors. 2001, Pubmed
Fitzgerald, Functional expression of cone cyclic nucleotide-gated channel in cone photoreceptor-derived 661W cells. 2008, Pubmed
Fox, Calcium overload triggers rod photoreceptor apoptotic cell death in chemical-induced and inherited retinal degenerations. 1999, Pubmed
Frasson, Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. 1999, Pubmed
Furman, Photoreceptor channel activation: interaction between cAMP and cGMP. 1989, Pubmed
Gerstner, Molecular cloning and functional characterization of a new modulatory cyclic nucleotide-gated channel subunit from mouse retina. 2000, Pubmed
Goto-Omoto, Compound heterozygous CNGA3 mutations (R436W, L633P) in a Japanese patient with congenital achromatopsia. 2006, Pubmed
Gómez-Vicente, Multiple death pathways in retina-derived 661W cells following growth factor deprivation: crosstalk between caspases and calpains. 2005, Pubmed
Gómez-Vicente, Induction of BIM(EL) following growth factor withdrawal is a key event in caspase-dependent apoptosis of 661W photoreceptor cells. 2006, Pubmed
Haynes, Block of the cyclic GMP-gated channel of vertebrate rod and cone photoreceptors by l-cis-diltiazem. 1992, Pubmed
He, Probing the interactions between cAMP and cGMP in cyclic nucleotide-gated channels using covalently tethered ligands. 2001, Pubmed , Xenbase
Huang, Autosomal recessive retinitis pigmentosa caused by mutations in the alpha subunit of rod cGMP phosphodiesterase. 1995, Pubmed
Ivanova, Circadian rhythm and photic control of cAMP level in chick retinal cell cultures: a mechanism for coupling the circadian oscillator to the melatonin-synthesizing enzyme, arylalkylamine N-acetyltransferase, in photoreceptor cells. 2003, Pubmed
Johnson, Achromatopsia caused by novel mutations in both CNGA3 and CNGB3. 2004, Pubmed
Kelsell, Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant cone-rod dystrophy. 1998, Pubmed
Koeppen, Dissecting the pathogenic mechanisms of mutations in the pore region of the human cone photoreceptor cyclic nucleotide-gated channel. 2010, Pubmed
Kohl, Total colourblindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel. 1998, Pubmed
Kohl, CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia. 2005, Pubmed
Kohl, Mutations in the CNGB3 gene encoding the beta-subunit of the cone photoreceptor cGMP-gated channel are responsible for achromatopsia (ACHM3) linked to chromosome 8q21. 2000, Pubmed
Korenbrot, Tuning outer segment Ca2+ homeostasis to phototransduction in rods and cones. 2002, Pubmed
Krishnamoorthy, Photo-oxidative stress down-modulates the activity of nuclear factor-kappaB via involvement of caspase-1, leading to apoptosis of photoreceptor cells. 1999, Pubmed
Liu, Functional consequences of progressive cone dystrophy-associated mutations in the human cone photoreceptor cyclic nucleotide-gated channel CNGA3 subunit. 2005, Pubmed , Xenbase
Matveev, The disease-causing mutations in the carboxyl terminus of the cone cyclic nucleotide-gated channel CNGA3 subunit alter the local secondary structure and interfere with the channel active conformational change. 2010, Pubmed
McLatchie, Voltage-dependent block by L-cis-diltiazem of the cyclic GMP-activated conductance of salamander rods. 1992, Pubmed
Michaelides, Progressive cone dystrophy associated with mutation in CNGB3. 2004, Pubmed
Michalakis, Impaired opsin targeting and cone photoreceptor migration in the retina of mice lacking the cyclic nucleotide-gated channel CNGA3. 2005, Pubmed
Muraki-Oda, Functional analysis of rod monochromacy-associated missense mutations in the CNGA3 subunit of the cone photoreceptor cGMP-gated channel. 2007, Pubmed
Nakamizo, Phosphodiesterase inhibitors are neuroprotective to cultured spinal motor neurons. 2003, Pubmed
Nicotera, The role of calcium in apoptosis. 1998, Pubmed
Nishiguchi, Cone cGMP-gated channel mutations and clinical findings in patients with achromatopsia, macular degeneration, and other hereditary cone diseases. 2005, Pubmed
Okada, Functional role of hCngb3 in regulation of human cone cng channel: effect of rod monochromacy-associated mutations in hCNGB3 on channel function. 2004, Pubmed
Pagès, Coexpression of alpha and beta subunits of the rod cyclic GMP-gated channel restores native sensitivity to cyclic AMP: role of D604/N1201. 2000, Pubmed
Paquet-Durand, Calpain is activated in degenerating photoreceptors in the rd1 mouse. 2006, Pubmed
Paquet-Durand, A key role for cyclic nucleotide gated (CNG) channels in cGMP-related retinitis pigmentosa. 2011, Pubmed
Patel, Transmembrane S1 mutations in CNGA3 from achromatopsia 2 patients cause loss of function and impaired cellular trafficking of the cone CNG channel. 2005, Pubmed
Payne, A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chromosome 6p21.1. 1998, Pubmed
Peng, Achromatopsia-associated mutation in the human cone photoreceptor cyclic nucleotide-gated channel CNGB3 subunit alters the ligand sensitivity and pore properties of heteromeric channels. 2003, Pubmed , Xenbase
Peng, Functionally important calmodulin-binding sites in both NH2- and COOH-terminal regions of the cone photoreceptor cyclic nucleotide-gated channel CNGB3 subunit. 2003, Pubmed , Xenbase
Peng, Subunit configuration of heteromeric cone cyclic nucleotide-gated channels. 2004, Pubmed , Xenbase
Pierce, Pathways to photoreceptor cell death in inherited retinal degenerations. 2001, Pubmed
Pugh, Cyclic GMP and calcium: the internal messengers of excitation and adaptation in vertebrate photoreceptors. 1990, Pubmed
Pugh, Molecular mechanisms of vertebrate photoreceptor light adaptation. 1999, Pubmed
Rattner, Molecular genetics of human retinal disease. 1999, Pubmed
Rebrik, In intact mammalian photoreceptors, Ca2+-dependent modulation of cGMP-gated ion channels is detectable in cones but not in rods. 2004, Pubmed
Reuter, Mutations in CNGA3 impair trafficking or function of cone cyclic nucleotide-gated channels, resulting in achromatopsia. 2008, Pubmed
Rohrer, Multidestructive pathways triggered in photoreceptor cell death of the rd mouse as determined through gene expression profiling. 2004, Pubmed
Rojas, A frameshift insertion in the cone cyclic nucleotide gated cation channel causes complete achromatopsia in a consanguineous family from a rural isolate. 2002, Pubmed
Sancho-Pelluz, Photoreceptor cell death mechanisms in inherited retinal degeneration. 2008, Pubmed
Sanges, Apoptosis in retinal degeneration involves cross-talk between apoptosis-inducing factor (AIF) and caspase-12 and is blocked by calpain inhibitors. 2006, Pubmed
Sharma, Calcium-induced calpain mediates apoptosis via caspase-3 in a mouse photoreceptor cell line. 2004, Pubmed
Soo, Light adaptation in salamander L-cone photoreceptors. 2008, Pubmed
Sundin, Genetic basis of total colourblindness among the Pingelapese islanders. 2000, Pubmed
Tan, Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. 2004, Pubmed
Tanaka, Photoreceptor channel activation by nucleotide derivatives. 1989, Pubmed
Taraska, Mapping the structure and conformational movements of proteins with transition metal ion FRET. 2009, Pubmed
Tetreault, Retinoids restore normal cyclic nucleotide sensitivity of mutant ion channels associated with cone dystrophy. 2006, Pubmed , Xenbase
Thapa, Endoplasmic reticulum stress-associated cone photoreceptor degeneration in cyclic nucleotide-gated channel deficiency. 2012, Pubmed
Traverso, Retinal cAMP levels during the progression of retinal degeneration in rhodopsin P23H and S334ter transgenic rats. 2002, Pubmed
Travis, Mechanisms of cell death in the inherited retinal degenerations. 1998, Pubmed
Tränkner, Molecular basis of an inherited form of incomplete achromatopsia. 2004, Pubmed
Tucker, Biochemical analysis of a dimerization domain mutation in RetGC-1 associated with dominant cone-rod dystrophy. 1999, Pubmed
Tuohy, Sensitivity of photoreceptor-derived cell line (661W) to baculoviral p35, Z-VAD.FMK, and Fas-associated death domain. 2002, Pubmed
Vallazza-Deschamps, Excessive activation of cyclic nucleotide-gated channels contributes to neuronal degeneration of photoreceptors. 2005, Pubmed
Valverde, A novel mutation in exon 17 of the beta-subunit of rod phosphodiesterase in two RP sisters of a consanguineous family. 1996, Pubmed
Varnum, Molecular mechanism for ligand discrimination of cyclic nucleotide-gated channels. 1995, Pubmed
Wang, Modulation of acid-sensing ion channel currents, acid-induced increase of intracellular Ca2+, and acidosis-mediated neuronal injury by intracellular pH. 2006, Pubmed
Wei, Substituted cGMP analogs can act as selective agonists of the rod photoreceptor cGMP-gated cation channel. 1998, Pubmed , Xenbase
Wissinger, CNGA3 mutations in hereditary cone photoreceptor disorders. 2001, Pubmed
Wiszniewski, Achromatopsia: the CNGB3 p.T383fsX mutation results from a founder effect and is responsible for the visual phenotype in the original report of uniparental disomy 14. 2007, Pubmed
Yoshimura, [Retinal neuronal cell death: molecular mechanism and neuroprotection]. 2001, Pubmed
Zagotta, Structural basis for modulation and agonist specificity of HCN pacemaker channels. 2003, Pubmed
Zhang, Protein folding in the endoplasmic reticulum and the unfolded protein response. 2006, Pubmed